Polar Capital Holdings Plc

Q3 2022 13F-HR Holdings

Location
London, X0
Holdings as of
9/30/2022
Date filed
11/14/2022
Form type
13F-HR
Num holdings
416
Total value ($000)
$15,693,872
Net value change ($000)
-1,333,010 (-7.8%)
New positions
21
Sold out positions
45
Turnover %
6.7%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Snapshot: Change Analysis

Compared to Q2 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Revance Therapeutics, Inc. 77,389 179.6%
DXCM 67,247 NEW
PEN 65,813 3145.9%
BDX 55,170 NEW
ABNB 54,616 106.6%
GTLB 51,530 NEW
TER 48,362 NEW
NET 44,297 329.1%
AMZN 43,441 32.7%
GLOB 42,564 301.1%
Top Reduces (Value $000, Stocks/ETFs)
Ferguson (Jersey) Ltd -780,534 -19.0%
MSFT -101,204 -11.6%
ADBE -85,203 -100.0%
STE -78,203 -100.0%
BABA -69,746 -50.0%
FIVN -65,089 -58.6%
CVS -62,913 -100.0%
NBIX -57,977 -75.8%
ZM -57,296 -100.0%
NVST -56,365 -88.3%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type